EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

6.31
Delayed Data
As of May 05
 -0.40 / -5.96%
Today’s Change
3.78
Today|||52-Week Range
16.90
+11.29%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close6.71
Today’s open6.72
Day’s range6.19 - 6.83
Volume161,626
Average volume (3 months)325,764
Market cap$157.8M
Dividend yield--
Data as of 3:59pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+75.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...-0.40-4.98%
GLYCGlycoMimetics Inc+0.05+0.59%
EGLTEgalet Corp-0.46-4.93%
AKBAAkebia Therapeutics ...-0.07-0.88%
Data as of 3:59pm ET, 05/05/2015

Financials

Last reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers